Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Analytical and Bioanalytical Chemistry|November 7, 2006
Recent developments in methods and technology for analysis of biological samples by MALDI-TOF-MSChensong Pan, Songyun Xu, Houjiang Zhou, et al.Electrophoresis|November 27, 2004
Enzymatic reaction of the immobilized enzyme on porous silicon studied by matrix-assisted laser desorption/ionization-time of flight-mass spectrometrySongyun Xu, Chensong Pan, Ligang Hu, et al.Rapid Communications in Mass Spectrometry : RCM|May 6, 2006
Iminodiacetic acid derivatized porous silicon as a matrix support for sample pretreatment and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysisSongyun Xu, Houjiang Zhou, Chensong Pan, et al.Journal of Separation Science|June 1, 2007
Enrichment of peptides from plasma for peptidome analysis using multiwalled carbon nanotubesXin Li, Songyun Xu, Chensong Pan, et al.Electrophoresis|June 1, 2007
Highly specific enrichment of phosphopeptides by zirconium dioxide nanoparticles for phosphoproteome analysisHoujiang Zhou, Ruijun Tian, Mingliang Ye, et al.Journal of the American Society for Mass Spectrometry|May 24, 2005
Using oxidized carbon nanotubes as matrix for analysis of small molecules by MALDI-TOF MSChensong Pan, Songyun Xu, Ligang Hu, et al.Journal of Chromatography. A|September 20, 2006
Biological fingerprinting analysis of the interactome of a kinase inhibitor in human plasma by a chemiproteomic approachRuijun Tian, Xinning Jiang, Xin Li, et al.Journal of Proteome Research|September 2, 2006
Zirconium phosphonate-modified porous silicon for highly specific capture of phosphopeptides and MALDI-TOF MS analysisHoujiang Zhou, Songyun Xu, Mingliang Ye, et al.Analytical Chemistry|June 5, 2008
Capture of phosphopeptides using alpha-zirconium phosphate nanoplateletsSongyun Xu, John C Whitin, Tom To-Sang Yu, et al.European Journal of Medicinal Chemistry|October 2, 2025
Highly potent and selective degrader targeting ERα to improve the treatment outcomes of breast cancerXueting Bao, Xunkai Yin, Jinjing Xu, et al.Pageof 2